Since establishing our private equity strategy in 1989, we have invested in over 415 private equity investments in 42 countries.

Filter by
Sort by
Company Country Sector Description Deal type Invest. date
Simtra BioPharma Solutions

Country United States Sector Healthcare Description Leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharmaceutical and biotech industries Deal type Carve-out Invest. date Sep 2023
Suven Pharmaceuticals

Country India Sector Healthcare Description A leader in the India pharma CDMO space Deal type Other Invest. date Sep 2023
ICE Pharma

Country Italy Sector Healthcare Description A global leader in the production of Ursodeoxycholic Acid (UDCA) used for the treatment of gastric and chronic diseases Deal type Buyout Invest. date Sep 2019
BioDuro

Country China Sector Healthcare Description A leading global life sciences contract research and development organization Deal type Buyout Invest. date Jan 2019
Zentiva

Country Czech Republic Sector Healthcare Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas Deal type Carve-out Invest. date Sep 2018
Genoa Healthcare

Country United States Sector Healthcare Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community Deal type Buyout Invest. date Apr 2015
Mediq

Country Netherlands Sector Healthcare Description Global provider of pharmaceuticals, medical devices and related care services Deal type Public-to-private Invest. date Feb 2013
Grupo Biotoscana

Country Colombia Sector Healthcare Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America Deal type Buyout Invest. date Nov 2011
Laboratorio LKM

Country Argentina Sector Healthcare Description One of the leading specialty pharmaceutical manufacturers in Argentina Deal type Buyout Invest. date Oct 2011
Labormed

Country Romania Sector Healthcare Description Romanian pharmaceutical manufacturer and distributor Deal type Buyout Invest. date Feb 2008
Terapia

Country Romania Sector Healthcare Description Romania's largest independent generic pharmaceuticals manufacturer Deal type Public-to-private Invest. date Aug 2003
Aviagen

Country United Kingdom Sector Healthcare Description World's leading meat poultry breeding company Deal type Buyout Invest. date May 2003
Viatris

Country Germany Sector Healthcare Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals Deal type Carve-out Invest. date Aug 2002
Fada Pharma

Country Argentina Sector Healthcare Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market Deal type Buyout Invest. date Jan 2001
Tropon

Country Germany Sector Healthcare Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) Deal type Carve-out Invest. date Mar 2000
Alcala Farma

Country Spain Sector Healthcare Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products Deal type Growth equity Invest. date Sep 1999
Trinity Pharmaceuticals

Country United Kingdom Sector Healthcare Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications Deal type Carve-out Invest. date Mar 1997
3i - Implant Innovations Inc.

Country United States Sector Healthcare Description Manufacturer of dental implants Deal type Growth equity Invest. date May 1995
Telik

Country United States Sector Healthcare Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics) Deal type Growth equity Invest. date Nov 1994
Esaote Biomedica

Country Italy Sector Healthcare Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment Deal type Privatization Invest. date Jul 1994
Transcend Therapeutics

Country United States Sector Healthcare Description Company formed to develop novel pharmaceuticals for the critical-care market Deal type Growth equity Invest. date Apr 1994

© 2002-2024 Advent International, L.P. All rights reserved

LinkedIn